Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 CEDRA Corporation | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

CEDRA Corporation

John F. Pottier has been appointed senior director of business development in CEDRA’s Generics unit.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

John F. Pottier has been appointed senior director of business development in CEDRA’s Generics unit. He has more than 17 years within the sales and marketing sector of the CRO market with extensive experience in building accounts within the pharmaceutical, generic and biotech industries.

“We are thrilled to have John join us,” said CEDRA chief executive officer Anthony G. Busa, Jr. “His experience with generic drug development programs, teaming up with our expertise in study design and regulatory knowledge, will continue to ensure smooth, efficient bioequivalence studies for our clients. John’s addition will benefit CEDRA in a number of ways and help to ignite the expansion of our generics division.”

Prior to joining CEDRA, Mr. Pottier held positions with Novum Pharmaceutical Research Services and PRACS Institute, Ltd./Cetero Research, all of which were related to business development and enhancing sales and marketing strategies.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics